![]() Shauna Sottery Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 407 Bayview Dr, Mt Pleasant, SC 29464 Phone: 203-605-1399 |
![]() Ms. Marie W. Carter, MA MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1103 Musket Range St, Mt Pleasant, SC 29464 Phone: 843-412-4444 Fax: 843-216-1113 |
![]() Ms. Laura Upton Norman, MED LPC Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 222 West Coleman Blvd, Suite 215, Mt Pleasant, SC 29464 Phone: 843-270-0680 Fax: 843-881-0358 |
![]() Ms. Julie R. Baker, JULIE R. BAKER,LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 222 W Coleman Blvd, Suite 117, Mt Pleasant, SC 29464 Phone: 843-881-8832 Fax: 843-881-0358 |
![]() Kirsten R Hatcher, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1541 Cypress Pointe Dr, Mt Pleasant, SC 29466 Phone: 843-901-2324 |
News Archive
Sunesis Pharmaceuticals, Inc. has announced a presentation of updated interim results from an ongoing Phase 2 clinical trial demonstrating that the Company's lead product candidate, voreloxin, shows promising efficacy and safety as a single agent in patients with platinum-resistant ovarian cancer.
We know that too many Americans can't afford primary care and end up in the emergency room with asthma or heart failure. But in the debate over health care coverage, less attention has been paid to the fact that too many Americans also end up in the emergency room with severe tooth abscesses that keep them from eating or infections that can travel from decayed teeth to the brain and, if untreated, kill.
Dr. Ian McGowan, a professor of medicine at the University of Pittsburgh who is leading a second-phase study of the gel said, "These are early results, but [they] help set the stage for current and future trials of rectal microbicides and the development of a rectal-specific formulation of tenofovir gel." Researchers have focused on the use of microbicides such as tenofovir, as a preventive treatment to be used in vaginal sex. However, scientists think unprotected anal sex is much more risky.
Clementia Pharmaceuticals, Inc. today announced that it has commenced enrollment in the second part (Part B) of its natural history study in patients with fibrodysplasia ossificans progressiva (FOP), a rare, severely disabling congenital myopathy characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) that result in the formation of new, abnormal (heterotopic) bone in muscles, tendons and ligaments.
› Verified 1 days ago